These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Release of acetylhydrolase from platelets on aggregation with platelet-activating factor. Suzuki Y, Miwa M, Harada M, Matsumoto M. Eur J Biochem; 1988 Feb 15; 172(1):117-20. PubMed ID: 3345757 [Abstract] [Full Text] [Related]
11. Platelet activating-factor acetylhydrolase II: A member of phospholipase A2 family that hydrolyzes oxidized phospholipids. Dong L, Li Y, Wu H. Chem Phys Lipids; 2021 Sep 15; 239():105103. PubMed ID: 34116047 [Abstract] [Full Text] [Related]
12. Anti-apoptotic actions of the platelet-activating factor acetylhydrolase I alpha2 catalytic subunit. Bonin F, Ryan SD, Migahed L, Mo F, Lallier J, Franks DJ, Arai H, Bennett SA. J Biol Chem; 2004 Dec 10; 279(50):52425-36. PubMed ID: 15456758 [Abstract] [Full Text] [Related]
13. cDNA cloning and expression of biologically active platelet activating factor-acetylhydrolase (PAF-AH) from bovine mammary gland. Lee E, Lee SJ, Lee TY, Chang HW. Biol Pharm Bull; 2005 Apr 10; 28(4):580-3. PubMed ID: 15802790 [Abstract] [Full Text] [Related]
14. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Tjoelker LW, Wilder C, Eberhardt C, Stafforini DM, Dietsch G, Schimpf B, Hooper S, Le Trong H, Cousens LS, Zimmerman GA, Yamada Y, McIntyre TM, Prescott SM, Gray PW. Nature; 1995 Apr 06; 374(6522):549-53. PubMed ID: 7700381 [Abstract] [Full Text] [Related]
15. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein. Tsoukatos DC, Liapikos TA, Tselepis AD, Chapman MJ, Ninio E. Biochem J; 2001 Jul 15; 357(Pt 2):457-64. PubMed ID: 11439095 [Abstract] [Full Text] [Related]
16. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. Stremler KE, Stafforini DM, Prescott SM, Zimmerman GA, McIntyre TM. J Biol Chem; 1989 Apr 05; 264(10):5331-4. PubMed ID: 2494162 [Abstract] [Full Text] [Related]
17. Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release. Touqui L, Herpin-Richard N, Gene RM, Jullian E, Aljabi D, Hamberger C, Vargaftig BB, Dessange JF. J Allergy Clin Immunol; 1994 Jul 05; 94(1):109-19. PubMed ID: 8027488 [Abstract] [Full Text] [Related]
18. The effect of exenatide (a GLP-1 analog) and sitagliptin (a DPP-4 inhibitor) on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and concentration in normal and fructose-fed rats. Wójcicka G, Zaręba M, Warpas A, Jamroz-Wiśniewska A, Rusek M, Czechowska G, Bełtowski J. Eur J Pharmacol; 2019 May 05; 850():180-189. PubMed ID: 30768981 [Abstract] [Full Text] [Related]
19. Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolase. Liu J, Chen R, Marathe GK, Febbraio M, Zou W, McIntyre TM. Circ Res; 2011 Feb 18; 108(4):469-77. PubMed ID: 21183738 [Abstract] [Full Text] [Related]
20. Plasma platelet activating factor-acetylhydrolase (PAF-AH). Karasawa K, Harada A, Satoh N, Inoue K, Setaka M. Prog Lipid Res; 2003 Mar 18; 42(2):93-114. PubMed ID: 12547653 [Abstract] [Full Text] [Related] Page: [Next] [New Search]